Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival

Author： Saif Muhammad Wasif   Hashmi Sharukh   Bell Diana   Diasio Robert B  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.8, Iss.5, 2009-09, pp. : 507-514

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Thymidine Phosphorylase in Biomodulation of Fluoropyrimidines

By  

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 3, 2001-09 ,pp. : 257-267

Bentham Science Publishers

Access to resources Recommend Favorite

Thymidine Phosphorylase Over-Expression in Oral Squamous Carcinoma Tissue as a Potential Target of Capecitabine

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 1, 2004-01 ,pp. : 45-49

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic Syndrome of Dihydropyrimidine Dehydrogenase Deficiency

By  

Current Pharmacogenomics, Vol. 5, Iss. 1, 2007-03 ,pp. : 31-38

Bentham Science Publishers

Access to resources Recommend Favorite

Eniluracil: an irreversible inhibitor of dihydropyrimidine dehydrogenase

By Kindler H.L.   Schilsky R.L.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. : 1635-1649

Informa Healthcare

Access to resources Recommend Favorite

Pancreatic Adenocarcinoma

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 10, 2007-11 ,pp. : 998-998

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite